The deadly superbug fungus known as Candida auris has continued to spread rapidly through hospitals in the U.S., mainly in the states of New York and New Jersey.
When we last reported on the outbreak in March, there were 35 confirmed cases of the disease, 28 of them located in New York State.
Currently, there are at least 61 cases of Candida auris infection in the United States – 39 in New York, 17 in New Jersey, 4 in Illinois, and one case each in Indiana, Maryland and Massachusetts.
According to the CDC, cases of C. auris in the U.S. have increased by more than 800 percent since the fall.
The disease is certainly of serious concern, with a roughly 60 percent mortality rate and the potential to become widespread throughout the nation’s hospitals.
“It’s acting like a superbug,” said Paige Armstrong of the CDC. “Without appropriate infection control and really a rigorous response, [it] could lead to even more cases in the United States.”
Preventing the spread of the superbug may prove to be as difficult as treating it.
From Managed Care Mag:
“Some strains of C. auris are resistant to all three major classes of antifungal drugs, according to the CDC. This type of multidrug resistance has not been seen before in other species of Candida. Also of concern, C. auris can persist on surfaces in health care environments and spread between patients in health care facilities, unlike most other Candida species. C. auris is also difficult to identify with standard laboratory methods and can be misidentified in laboratories without specific technology.”
Even CDC acting director Dr. Anne Schuchat admitted that the fungus poses a “catastrophic threat,” and that officials “have to do better with infection control.”
We appear to be nearing the end of the era in which infections can be treated effectively using antibiotics and anti-fungal drugs. Due to widespread overuse, the antibiotics we have depended on are becoming increasingly ineffective as bacteria mutate into ever-more-resistant strains, and no new classes of antibiotics are being developed – primarily due to the fact that it isn’t a profitable venture for Big Pharma.
Mainstream medicine has no answers and no plan in place to deal with a future in which infections cannot be controlled. A mutant strain of drug-resistant bacteria could wipe out tens or even hundreds of millions of people, and there will be nothing we can do to stop it.
In essence, we’ve reverted back to the days before antibiotics were discovered – when bacterial or fungal infections often ran rampant through populations, such as in the days of the Black Plague.
But even in those times, there were those who survived the various diseases they were exposed to simply because their immune systems were strong and healthy. Those with knowledge of medicinal plants and natural remedies had an even better chance of survival.
Many of those traditional natural remedies can be used just as effectively today. For example, oil of oregano might well prove to be more successful at containing C. auris than the useless anti-fungal drugs currently being used to fight the disease.
Oil of oregano is one of the most powerful antibiotic and anti-fungal agents known.
From Natural News:
“Oil of oregano handles pathogenic bacteria without disrupting beneficial bacteria. It is also anti-viral and anti-fungal. This is a rare three in one combination. Imagine destroying fungal colonies while ridding oneself of a bacterial or viral infection and preserving your good bacteria.”
Perhaps when all the pharma drugs fail and many people begin dying from simple infections, the medical drug cartels will finally begin to acknowledge the benefits of natural plant-based anti-fungal and antibiotic remedies that actually work.
Let’s hope we don’t have to wait that long.